Tonight on Your Health First, Jeffrey Loo from Standard & Poor's will be joing Dr. Joe Galati and Chuck Garcia as they discuss the Wall Street aspects of hepatitis C and the new drugs that are being developed.

Below are links related to Hepatitis C and Wall Street

Why to Watch Gilead and the New Hepatitis C Medicines

New Hepatitis C Guidelines and Wall Street

Gilead Science and Standard & Poor's